- Home
- ELVN vs ITGR Comparison
ELVN vs ITGR Comparison
Compare ELVN & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | ITGR |
|---|---|---|
| Founded | 2016 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.9B |
| IPO Year | 2020 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ELVN | ITGR |
|---|---|---|
| Price | $41.67 | $89.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $43.40 | ★ $91.14 |
| AVG Volume (30 Days) | 570.7K | ★ 576.7K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | N/A | $1.69 |
| Revenue Next Year | N/A | $6.53 |
| P/E Ratio | ★ N/A | $187.42 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $14.79 | $62.00 |
| 52 Week High | $48.53 | $123.78 |
Technical Indicators
Market Signals| Indicator | ELVN | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 54.97 |
| Support Level | $16.84 | $82.58 |
| Resistance Level | $45.14 | $106.08 |
| Average True Range (ATR) | 2.38 | 2.64 |
| MACD | -0.21 | 0.35 |
| Stochastic Oscillator | 48.17 | 74.67 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.